These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4352402)

  • 1. Immunohistochemical demonstration of glucagon in an A 2 -cell carcinoma.
    Larsson LI; Sundler F; Grimelius L; Håkanson R; Holst J
    Experientia; 1973 Jun; 29(6):698-9. PubMed ID: 4352402
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of glucagon in islet cell adenomas of the pancreas by immunofluorescent technic.
    Lomský R; Langr F; Vortel V
    Am J Clin Pathol; 1969 Feb; 51(2):245-50. PubMed ID: 4304016
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistologic investigations of human insulinomas.
    Arnold R; Deuticke U; Frerichs H; Creutzfeldt W
    Diabetologia; 1972 Aug; 8(4):250-9. PubMed ID: 4344285
    [No Abstract]   [Full Text] [Related]  

  • 4. A glucagon-secreting alpha-cell carcinoma of the pancreas.
    McGavran MH; Unger RH; Recant L; Polk HC; Kilo C; Levin ME
    N Engl J Med; 1966 Jun; 274(25):1408-13. PubMed ID: 4286757
    [No Abstract]   [Full Text] [Related]  

  • 5. Demonstration of insulin in an islet cell pancreatic adenoma using an immunofluorescent technique.
    Thomsen OF
    Acta Pathol Microbiol Scand A; 1972; 80(5):689-90. PubMed ID: 4117137
    [No Abstract]   [Full Text] [Related]  

  • 6. ACTH, glucagon and gastrin production by a pancreatic islet cell carcinoma and its treatment.
    Belchetz PE; Brown CL; Makin HL; Trafford DJ; Mason AS; Bloom SR; Ratcliffe JG
    Clin Endocrinol (Oxf); 1973 Oct; 2(4):307-16. PubMed ID: 4358344
    [No Abstract]   [Full Text] [Related]  

  • 7. Morphology and immunohistochemically-defined endocrine function of pancreatic islet cell tumours.
    Kruseman AC; Knijnenburg G; de la Riviere GB; Bosman FT
    Histopathology; 1978 Nov; 2(6):389-99. PubMed ID: 215502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical presentation of hormone producing cells in the pancreatic tissue of patients with hyperinsulinism].
    Függer R; Ulrich W; Krepler R; Hölbling N; Funovics J; Denk H
    Pathologe; 1982 Nov; 3(6):329-32. PubMed ID: 6296808
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glucagonoma].
    Shima K; Tsujii T; Sasano N; Doi O; Kyoba S
    Gan No Rinsho; 1970 Aug; 16(8):866-70. PubMed ID: 4318397
    [No Abstract]   [Full Text] [Related]  

  • 10. [A glucagon-secreting alpha-cell carcinoma of the pancreas].
    Matsumoto J; Noto N; Kikuchi Y; Kitazima S; Kaimori M; Sasaki G; Ohto T; Nakamura K
    Nihon Shokakibyo Gakkai Zasshi; 1985 Feb; 82(2):330-4. PubMed ID: 2987580
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
    Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
    Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon synthesis with mRNA preparation of a glucagon-producing tumor (IT-1).
    Sato J
    Endocrinol Jpn; 1989 Oct; 36(5):755-65. PubMed ID: 2559841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours.
    Holst JJ
    Diabetologia; 1983 May; 24(5):359-65. PubMed ID: 6307793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic islet cell tumor with ACTH, gastrin, and glucagon secretion. Clinical and pathologic studies with multiple therapies.
    Lokich J; Bothe A; O'Hara C; Federman M
    Cancer; 1987 Jun; 59(12):2053-8. PubMed ID: 3032401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine tumors of the pancreas: clinical, chemical and morphological findings.
    Creutzfeldt W
    Monogr Pathol; 1980; 21():208-30. PubMed ID: 6111748
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hormonal islet cell tumors. Proposition of a diagnostic-therapeutic model].
    Legutko J; Hartwich A; Szpakowicz J; Kedra B; Haxhijaha S; Malik L
    Przegl Lek; 1998; 55(9):463-8. PubMed ID: 10085725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic islet cell tumour with clinical manifestations of insulin and glucagon excess: successful treatment by hepatic artery embolization and chemotherapy.
    Lee SM; Forbes A; Williams R
    Eur J Surg Oncol; 1988 Jun; 14(3):265-8. PubMed ID: 2836237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic glucagon excess on hepatic metabolism.
    Boden G; Wilson RM; Owen OE
    Diabetes; 1978 Jun; 27(6):643-8. PubMed ID: 207608
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistologic study of thyroidal medullary carcinoma and pancreatic insulinoma.
    Arnal-Monreal FM; Goltzman D; Knaack J; Wang NS; Huang SN
    Cancer; 1977 Sep; 40(3):1060-70. PubMed ID: 198085
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential glucocorticoid regulation of glucagon gene expression in cell lines derived from rat and hamster islet cell tumors.
    Wang C; Campos RV; Stobie KM; Brubaker PL; Drucker DJ
    Cancer Res; 1991 Feb; 51(4):1196-201. PubMed ID: 1705169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.